Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Tolerability and efficacy of pegylated interferon-α-2a in combination with imatinib for patients with chronic-phase chronic myeloid leukemia.

Authors
  • Johnson-Ansah, Hyacinthe
  • Guilhot, Joelle
  • Rousselot, Philippe
  • Rea, Delphine
  • Legros, Laurence
  • Rigal-Huguet, Françoise
  • Nicolini, Franck Emmanuel
  • Mahon, François-Xavier
  • Preudhomme, Claude
  • Guilhot, François
Type
Published Article
Journal
Cancer
Publisher
Wiley (John Wiley & Sons)
Publication Date
Dec 15, 2013
Volume
119
Issue
24
Pages
4284–4289
Identifiers
DOI: 10.1002/cncr.28328
PMID: 24105694
Source
Medline
Keywords
License
Unknown

Abstract

The results of the current study demonstrate that in combination with imatinib, the efficient dose of PegIFNa2a appears to be 45 μg/week. Society.

Report this publication

Statistics

Seen <100 times